Form D · Biotechnology
Ophthotech Corp.
New York, NY · CIK 0001410939
Offering snapshot reported Nov 2, 2018 · SEC filing
- Reported sold
- $11.4M Offering amount: $11.7M
- Investors reported
- 2 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Oct 30, 2018 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Nov 2, 2018 | Initial | $11,399,894 | No comparison | 2 | SEC filing |
| Jun 3, 2013 | Initial | $16,666,668 | No comparison | 7 | SEC filing |
| Mar 19, 2013 | Initial | $1 | No comparison | 1 | SEC filing |
| Jan 3, 2013 | Initial | $1 | No comparison | 1 | SEC filing |
| Jul 3, 2012 | Initial | $1 | No comparison | 1 | SEC filing |
| Dec 18, 2009 | Initial | $15,000,000 | No comparison | 7 | SEC filing |
| Oct 19, 2009 | Initial | $3,000,000 | No comparison | 5 | SEC filing |
| Aug 24, 2007 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- Yes
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-324993
Source: Form D, filed Nov 2, 2018. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Thomas Biancardi | Executive |
| Axel Bolte | Director |
| Alex Bolte | Director |
| David Carroll | Executive |
| Thomas Dyrberg | Director |
| Nicholas Galakatos | Director |
| Lutz Giebel | Director |
| David Guyer | Director, Executive |
| Evelyn Harrison | Executive |
| Jane Pritchett Henderson | Director |
| Samir C. Patel | Director, Executive |
| Bruce Peacock | Executive |
| David Redlick | Director |
| Michael Ross | Director |
| Glenn Sblendorio | Director, Executive |
| Henry Simon | Director |
| Keith Westby | Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
One Penn Plaza 35 Th Floor
New York, NY, 10119
New York, NY, 10119